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Impact in vocal quality in partial myectomy and neurectomy 
endoscopic of thyroarytenoid muscle in patients with 
adductor spasmodic dysphonia the adductor spasmodic 
dysphonia is a severe vocal disorder characterized by muscle 
laryngeal spasms during speech, producing phonatory breaks, 
forced, strained and strangled voice. Its symptoms come from 
involuntary and intermittent contractions of thyroarytenoid 
muscle during speech, which causes vocal fold strain, pressed 
one against another and increased glottic resistance. Aim: 
report the results in the impact in vocal quality in neurectomy 
of the thyroarytenoid branch of the inferior laryngeal nerve 
by endoscopic route associated with partial myectomy of the 
thyroarytenoid muscle with co2 laser. Material and method: 
the surgery was done in 07 patients ( 06 females and 01 male), 
aged 22 to 75, with adductor spasmodic dysphonia. They 
were submitted to vhi (voice handicap index) before and after 
surgery. Results and conclusions: the vocal improvement 
was obtained in all studied patients, deterioration in vocal 
quality after surgery was not noticed. There was evident 
difference in the vhi before and after surgery. This surgical 
thecnique proved to be efficient and innovative in the 
treatment of adductor spasmodic dysphonia.
Key words: Spasmodic dysphonia. Botulinum toxin. Dystonia. 
VHI.
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INTRODUCTION
Adduction spasmodic dysphonia is a vocal disorder 
characterized by laryngeal muscle spasms during speech, 
causing phonatory breaks, forced, strained and strangled 
voice1,2. This disorder, classified as central origin focal 
dystonia, of unknown etiology, remains one of the most 
difficult to treat dysphonias3. Its symptoms come for in-
termittent and involuntary contractions of thyroarytenoid 
muscles during speech1,4, resulting in tense vocal folds, 
pressed one against the other and increase in glottic 
resistance1,4.
It usually starts in the third decade of life, and it 
happens more frequently to women. Vocal quality wors-
ens, usually in response to stress, and there may be some 
improvement with the use of sedatives such as alcohol 
and benzodiazepins5. It may have a negative impact on 
the patient’s life quality and cause social isolation6.
Along the history of laryngology, different types 
of treatment have been proposed for this disease, such 
as surgeries on the larynx innervation7-10, a technique of 
chemical denervation of the thyroarytenoid muscle by 
the application of botulin toxin11, surgery on the larynx 
framework, such as types II3,12 and III13,14 thyroplasties, 
partial myectomy of the thyroaritenoid muscle with cold 
forceps, as proposed by Fukuda (1996)15 and CO
2
 laser 
surgery, proposed by Garcia Tapia (2000)16. Vocal therapy 
is not efficient n the treatment of spasmodic dysphonias, 
specially in moderate and severe cases17.
Currently, the injection of butulin toxin is considered 
a first choice method by most laryngologists18-20. This is 
maily due to the excellent vocal results attained and the 
ease of application. Among the disadvantages of such 
treatment we list: the need for reaplication every three to 
four months, vocal instability observed in the beginning 
and end of its action, lack of uniformity in the results, 
possibility of antibody production that may neutralize its 
effectiveness21,22, high cost of medication and the need for 
proper equipment used in its application20.
In face of short lasting results from partial thyroary-
tenoid myectomy seen by the author and published by 
Tsuji et al (2002)23, a new technique has been developed, 
in which we perform an endoscopic neurectomy of the thy-
roaritenoid branch of the inferior laryngeal nerve, together 
with partial myectomy of the thyroaritenoid muscle with 
a CO
2
25 laser. The goal of the present paper is to present 
preliminary results on vocal quality impact caused by this 
new techninque for the treatment of adduction spasmodic 
dysphonia treatment.
MATERIALS AND METHODS
From October 2001 to May 2005, the same sur-
geon (DHT), performed 7 endoscopic neurectomies of 
the thyroaritenoid branch of the inferior laryngeal nerve, 
together with partial myectomy of the thyroaritenoid mus-
cle with a CO
2
 laser in patients with adduction spasmodic 
dysphonia.
Patient selection criteria for surgery were: 1) ad-
duction spasmodic dysphonia diagnosis carried out by a 
team of otolaryngologists and speech therapists, 2) prior 
clinical improvement with the use of botulin toxin in the 
thyroaritenoid muscle, 3) patient’s choice to perform sur-
gery as a definitive treatment, 4) patients’ informed consent 
to perform the surgery.
Demographic data such as patients’ age and gender 
were obtained, together with a history of past treatments 
for that ailment.
Participants answered a questionnaire applied by 
one of the authors in the pre and postoperative, in which 
the voice impact on the life of these patients was as-
sessed. The questionnaire used was the VHI (attachment 
1), adapted to Portuguese, with 30 items. Each answer is 
scored from 0 to 4, and the final score varies from 0 to 120, 
and 120 points represents the maximum value of vocal 
involvement perception. At the end of VHI, the patients 
were asked about the percentage of improvement after 
surgery, and the answer was graded from 0 to 100%.
SURGICAL TECHNIQUE
Surgery is performed under general anesthesia, 
orotracheal intubation and microscopic visualization. 
We used a conventional suspension laryngoscope, used 
during conventional phonomicrosurgery to expose the 
glottic region. 
1st Step: Thyroaritenoid muscle partial myectomy
We do a partial myectomy of the thyroaritenoid 
muscle, vaporizing the lateral portion of the vocal fold 
with a CO
2
 laser (model 20C Sharplan), set at an intensity 
of 3.5 watts, in continuous superpulse mode, connected to 
a model M 900 DF-Vasconcelos surgical microscope, with 
a 400mm objective lens and straight eyepiece with a 12.5x 
lens. The vaporization medial limit corresponds to the line 
that lies approximately at 1mm lateral to the transitional 
line between the vibratory pars of the vocal fold and the 
floor of the laryngeal ventricle. We vaporize as much as 
possible laterally with the laser beam, sometimes even 
reaching the internal pericondrium of the thyroid cartilage. 
As anterior limit we take the internal pericondrium of the 
thyroid cartilage located laterally to the anterior vertex of 
the ventricle and, as posterior limit we use the region im-
mediately anterior to the posterior vertex of the laryngeal 
ventricle. The inferior limit is determined by tactile and 
visual estimates by the surgeon, who should try to vaporize 
the whole lateral thickness of the thyroaritenoid muscle, 
corresponding to 3mm to 5mm of depth.
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VHI (VOICE HANDICAP INDEX)
0 = NEVER 1 =ALMOST NEVER 2 =SOMETIMES 3 =ALMOST ALWAYS 4 =ALWAYS
PART I
1-Do people feel it difficult to understand your voice?
0 1 2 3 4
2-Do people feel it difficult to understand you in noise enviroments?
0 1 2 3 4
3-Do your family members have difficulty in understanding you when you call them within the house?
0 1 2 3 4
4- Do you use the telephone less often than you wish you could?
0 1 2 3 4
5- Do you avoid groups of people because of your voice?
0 1 2 3 4
6-Do you talk less to friends, neighbors and relatives because of your voice?
0 1 2 3 4
7- Do people ask you to repeat what you had just said when talking to you face to face?
0 1 2 3 4
8-Does your voice restrict your social and personnal life?
0 1 2 3 4
9-Do you feel excluded from discussions because of your voice?
0 1 2 3 4
10-Did your voice problem cause you to lose your job?
0 1 2 3 4
PART II
1-Do you feel short of breath when you talk?
0 1 2 3 4
2-Does your voice vary along the day?
0 1 2 3 4
3-Do people ask: What is wrong with your voice?
0 1 2 3 4
4-Does your voice seems dry or chiada?
0 1 2 3 4
5-Do you need to force yourself in order to produce your voice?
0 1 2 3 4
6-Is your voice clarity unpredictable?
0 1 2 3 4
7-Do you try to change your voice to sound different?
0 1 2 3 4
8-Do you strain yourself in order to speak?
0 1 2 3 4
9-Does your voice gets worse at the end of the day?
0 1 2 3 4
10- Does your voice fail in the middle of a conversation?
0 1 2 3 4
PART III
1-Does your voice quality stress you when you talk to people?
0 1 2 3 4
2-Are people irritated by your voice?
0 1 2 3 4
3-Do you think other people do not appreciate your voice problem?
0 1 2 3 4
4-Does your voice bother you?
0 1 2 3 4
5-Does your voice make you less sociable?
0 1 2 3 4
Attachment 1.
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6-Do you feel impaired by your voice problem?
0 1 2 3 4
7-Do you feel annoyed when people ask you to repeat what you had just said?
0 1 2 3 4
8-Do you feel embarassed when they ask you to repeat what you had just said?
0 1 2 3 4
9-Does your voice make you feel incompetent?
0 1 2 3 4
10-Are you ashamed of your voice problem?
0 1 2 3 4
Attachment 1. continuing.
2nd Step: Neurectomy of the thyroaritenoid branch of 
the inferior laryngeal nerve
Using the tip of the electric scalpel (its shape and 
size are presented on Figures 1a and 1b), connected to 
an electrocautere (SS-601MC model of the WEM brand, 
set for cutting at 10.0 of intensity), we cut the thyroarite-
noid branch of the inferior laryngeal nerve. The scalpel is 
introduced at the myectomy posterior limit, with its end 
initially turned posteriorly. After that we turn the scalpel 
in its own axis, between 45 and 90 degrees, in such a 
way as that the electrocautery tip is laterally positioned 
towards the cartilage pericondrium and allows it to reach 
the nerve. Following that, we perform vertical up and 
down movements with the electrocautere in an attempt to 
fish and section the nerve by electrocoagulation in order 
to guarantee the effectiveness in the nerve sectioning.
Surgery is performed in both vocal folds.
RESULTS
Patients’ages varied between 22 and 75 years, with 
an average of 49.1 years. There were 6 females and 1 male. 
The average follow up time was of 23.7 months.
Except for patient1, all the others had received 
many applications of botulin toxin. They chose surgical 
treatment because they were not pleased with the vocal 
instability brought about by the botulin toxin and also for 
having the possibility of a definitive improvement in their 
clinical symptoms.
Vocal improvement was achieved in all patients, and 
only in one patient (patient 3) was necessary to perform 
a surgical correction because of vocal fold arching, in 
whom the right-side sterno-hyoid muscle was transposed 
to the paraglottic space, according to Su et al.26, in order 
to improve glottic closure. There was no vocal quality 
Figure 1.  (a) Tip of the electrical scalpel;
 (b) Instrument angle and dimensions.
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deterioration along the pos-operative period, even in the 
first patients who underwent the technique, and they all 
have close to four year follow ups.
The procedure success was seen by the degree of 
patient satisfaction, with improvement in vocal quality and 
return to social activities. Table 1 depicts the results. There 
was a clear difference in VHI before and after surgery, 
when patients reported important functional, physical and 
emotional voice improvement after surgery. Most patients 
report over 70% of subjective improvement in voice quality 
after surgery, and this allows them to return to their daily 
activities. One patient could not be found, and therefore 
she did not answer the VHI after surgery.
DISCUSSION
Adduction spasmodic dysphonia is a severe disease, 
causing forced, strained and strangled voice, with breaks 
in its sonority, that may lead to an incapacity in oral com-
munication that is difficult to treat.
In 1976, Dedo was the first to perform surgical treat-
ment through the sectioning of the recurrent nerve, caus-
ing unilateral vocal cord paralysis. However, other studies 
performed27-32 showed that some patients had recurrencies 
of their vocal disorder after surgery.
In our settings, the injection of botulin toxin was 
introduced by Tsuji33 and remains the first choice method 
to treat adduction spasmodic dysphonia19,33. In some cases, 
surgery has been chosen as definitive treatment. Myectomy 
together with neurectomy of thyroarytenoid branch of 
the inferior laryngeal nerve is an alternative to the use of 
botulin toxin, because it is an easy to perform procedure, 
the endoscopic via is the access needed, it requires short 
surgical time, has little complication potential and offfrs 
the possibility of bearing definitive results.
However, the different therapeutic modes have 
shown that voice may be reasonably restored to a quality 
standard, if not totally normal, better than it was prior to 
surgery, since one achieves certain inactivity of the thy-
roaritenoid muscle, or a certain reduction on the degree 
of glottic closure, and this happens through surgery of 
the larynx framework. Both the recurrent nerve section-
ing technique and the isolate thyroaritenoid myectomy 
require cold forceps (Fukuda15). CO
2
 laser (described by 
Garcia Tapia16), and botulin toxin injection fail when the 
thyroarytenoid muscle resumes its total contractility (as 
we have in the case of toxin injection) or partial (in the 
case of the DEDO procedure, and, very likely, in the my-
ectomy). The mechanisms responsible for the thyroaryte-
noid muscle functional recovery, even if partial, after the 
aforementioned surgical approach are still not clear, but 
they are probably related to the reinervation of denerved 
muscle fibers.
When we associate the neurectomy of the thyroary-
tenoid branch of the inferior laryngeal nerve to thyroary-
tenoid muscle myectomy, we aim at preventing, or at 
least making it difficult, the reinervation of the remaining 
muscle from myectomy.
VHI was proposed by Jacobson et al.34 and describes 
the physical, emotional and functional impact voice has 
on the life of these people. In the present study, we used 
the questionnaire in patients with adduction spasmodic 
dysphonia who underwent thyroarytenoid muscle myec-
tomy together with the neurectomy of the nerve of the 
same name shows clear and long lasting improvement in 
voice when we considere the three aspects surveyed, with 
patient social and economical reintegration.
CONCLUSION
The neurectomy of the thyroarytenoid branch of the 
inferior laryngeal nerve together with partial myectomy of 
the thyroarytenoid muscle represents an efficient and in-
novative surgical technique for the treatment of adduction 
spasmodic dysfunction, and it may be a therapeutic option 
for those patients who seek a definitive improvement of 
their problem.
Table 1. VHI (Voice Handicap Index) scores per patient, carried out on August 2005.
Patient Age
(years)
Gender Profes-
sion
Preoperative 
VHI
Postoperative 
VHI 
Variation Subjective voice 
improvement
Time after surgery 
(months) 
1 44 F Seamster 110 1 109 80% 46
2 30 F Cachier 107 16 91 80% 46
3 54 F Secretary 101 66 35 70% 20
4 22 F Secretary 95 24 71 70% 41
5 67 M Priest 97 14 83 95% 20
6 52 F Secretary 102 20 82 80% 04
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